Evidence supporting the use of: Vitamin E (alpha tocopheryl acetate)
For the health condition: Cataracts

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 1

Vitamin E (especially as alpha tocopheryl acetate) has been investigated for its potential role in preventing or slowing the progression of cataracts, primarily due to its antioxidant properties. Cataracts are associated with oxidative stress in the lens of the eye, and Vitamin E is a lipid-soluble antioxidant that can protect cell membranes from oxidative damage. Epidemiological studies have observed that individuals with higher dietary intake of Vitamin E may have a lower risk of developing cataracts. However, randomized controlled trials and meta-analyses have generally failed to show a significant benefit of Vitamin E supplementation in preventing or treating cataracts. For example, the Age-Related Eye Disease Study (AREDS) did not find a significant reduction in cataract progression with Vitamin E supplementation. Similarly, Cochrane reviews and other systematic analyses have concluded that current evidence does not support a clinically meaningful effect of Vitamin E on cataract development or progression. Despite its widespread use in multivitamin formulations and theoretical rationale, the scientific evidence supporting Vitamin E as a treatment or preventive measure for cataracts is weak, and major ophthalmological guidelines do not recommend its use for this purpose.

More about Vitamin E (alpha tocopheryl acetate)
More about Cataracts

Products containing Vitamin E (alpha tocopheryl acetate)

We currently have no products on Vitabase that contain this ingredient.